Thiol/disulfide homeostasis and ischemia modified albumin levels in autoimmune gastritis and their relations with gastric emptying
Thiol/disulfide homeostasis and ischemia modified albumin levels in autoimmune gastritis and their relations with gastric emptying
Background/aim: Autoimmune gastritis is an autoimmune and inflammatory disorder. The aim of this study is to examine dynamicthiol/disulfide homeostasis and ischemia modified albumin levels, and to analyze the association between thiol/disulfide homeostasisand gastric emptying time in autoimmune gastritis.Materials and methods: Thiol/disulfide homeostasis tests and ischemia modified albumin levels were determined in 50 autoimmunegastritis patients and 53 healthy subjects. Patients with delayed and normal gastric emptying were compared by thiol/disulfidehomeostasis tests.Results: The results showed that native thiol (μmol/L), total thiol (μmol/L), and native thiol/total thiol ratio (%) of the patients withautoimmune gastritis decreased compared to the control group (177.7 ± 34.18 vs. 245.25 ± 33.83, P = 0.001, 227.25 ± 36.78 vs. 284.20± 27.19, P = 0.03, and 8.84 ± 1.1 vs. 7.74% ± 1.3%, P = 0.001). In addition, native thiol (μmol/L), total thiol (μmol/L), and native thiol/total thiol ratio (%) were found to be lower in patients with delayed gastric emptying (198.65 ± 24.27 vs. 167.12 ± 20.51, 241.81 ± 27.14vs. 213.92 ± 26.35, 8.34 ± 1.29 vs. 7.20 ± 1.83, P = 0.001). Disulfide level, disulfide/native thiol, disulfide/total thiol (P = 0.001) ratios,and ischemia modified albumin levels (ABSU, 0.71 ± 0.08 vs. 0.83 ± 0.07) were found to be higher in autoimmune gastritis patients withdelayed gastric emptying (P = 0.001).Conclusion: The results showed that thiol/disulfide homeostasis in patients with autoimmune gastritis caused an increase in ischemiamodified albumin and disulfide whereas a decrease in thiols. An altered thiol/disulfide balance was also observed in patients withdelayed gastric emptying. These results suggest that the oxidative process is involved in patients with autoimmune gastritis.
___
- 1. Neumann WL, Coss E, Rugge M, Genta RM. Autoimmune
atrophic gastritis—pathogenesis, pathology and management.
Nature Reviews Gastroenterology & Hepatology. 2013; 10 (9):
529-541. doi: 10.1038/nrgastro.2013.101
- 2. Ates I, Altay M, Yilmaz FM, Topcuoglu C, Neselioglu S et
al. Dynamic thiol/disulfide homeostasis in patients with
autoimmune subclinical hypothyroidism. Endocrine Research
2016; 41 (4): 343-349. doi: 10.3109/07435800.2016.1156124
- 3. Dogru A, Balkarli A, Cetin GY, Neselioglu S, Erel O et al. Thiol/
disulfide homeostasis in patients with ankylosing spondylitis.
Bosnian Journal of Basic Medical Sciences 2016; 16 (3): 187-
192. doi: 10.17305/bjbms.2016.1001
- 4. Sahin A, Erten S, Altunoglu A, Isikoglu S, Neselioglu S et al.
Comparison of serum oxidant and antioxidant parameters in
familial Mediterranean fever patients (FMF) with attack free
period. Acta Reumatologica Portuguesa 2014; 39 (4): 316-321.
- 5. Halliwell B, Gutteridge JMC. Lipid peroxidation, oxygen
radicals, cell damage, and antioxidant therapy. Lancet 1984; 1
(8391): 1396-1397. doi: 10.1016/s0140-6736(84)91886-5
- 6. Kayalı R, Cakatay U. Protein oksidasyonunun ana
mekanizmaları. Cerrahpasa Journal of Medicine 2002; 35: 83-
89 (in Turkish).
- 7. Sen CK, Packer L. Thiol homeostasis and supplements in
physical exercise. American Journal of Clinical Nutrition 2000;
72 (2 Suppl.): 653-669. doi: 10.1093/ajcn/72.2.653S
- 8. Cremers CM, Jakob U. Oxidant sensing by reversible disulfide
bond formation. Journal of Biological Chemistry 2013; 288
(37): 26489-26496. doi: 10.1074/jbc.R113.462929
- 9. Turell L, Radi Ralvarez B. The thiol pool in human plasma:
the central contribution of albumin to redox processes. Free
Radical Biology & Medicine 2013; 65: 244-253. doi: 10.1016/j.
freeradbiomed.2013.05.050
- 10. Biswas S, Chida AS, Rahman I. Redox modifications of
protein thiols: emerging roles in cell signaling. Biochemical
Pharmacology 2006; 71 (5): 551-564. doi: 10.1016/j.
bcp.2005.10.044
- 11. Circu ML, Aw TY. Reactive oxygen species, cellular redox
systems, and apoptosis. Free Radical Biology & Medicine 2010;
48 (6): 749-762. doi: 10.1016/j.freeradbiomed.2009.12.022
- 12. Valle Gottlieb MG, da Cruz IB, Duarte MM, Moresco RN,
Wiehe M et al. Associations among metabolic syndrome,
ischemia, inflammatory, oxidatives, and lipids biomarkers.
Journal of Clinical Endocrinology & Metabolism 2010; 95 (2):
586-591. doi: 10.1210/jc.2009-1592
- 13. Wudkowska A, Goch J, Goch A. Ischemia−modified albumin
in differential diagnosis of acute coronary syndrome without
ST elevation and unstable angina pectoris. Kardiologia Polska
2010; 68 (4): 431-437.
- 14. Erel O, Neselioglu S. A novel and automated assay for thiol/
disulphide homeostasis. Clinical Biochemistry 2014; 47 (18):
326-332. doi: 10.1016/j.clinbiochem.2014.09.026
- 15. Pavithran P, Nandeesha H, Sathiyapriya V, Bobby Z,
Madanmohan T. Short term heart variability and oxidative
stress in newly diagnosed essential hypertension. Clinical
and Experimental Hypertension 2008; 30 (7): 486-496. doi:
10.1080/10641960802251875
- 16. Vincent AM, Russell JW, Low P, Feldman EL. Oxidative stress
in the pathogenesis of diabetic neuropathy. Endocrine Reviews
2004; 25 (4): 612-628. doi: 10.1210/er.2003-0019
- 17. Ziegler D, Sohr CG, Nourooz-Zadeh J. Oxidative stress and
antioxidant defense in relation to the severity of diabetic
polyneuropathy and cardiovascular autonomic neuropathy.
Diabetes Care 2004; 27 (9): 2178-2183. doi: 10.2337/
diacare.27.9.2178
- 18. Kalkan C, Soydal C, Ozkan E, Maden A, Soykan I. Relationships
between autonomic nerve function and gastric emptying
in patients with autoimmune gastritis. Clinical Autonomic
Research 2016; 26 (3): 189-196. doi: 10.1007/s10286-016-
0353-y
- 19. Kalkan C, Soykan I, Soydal C, Ozkan E, Kalkan E. Assessment
of gastric emptying in patients with autoimmune gastritis.
Digestive Disease and Sciences 2016; 61 (6): 1597-1602. doi:
10.1007/s10620-015-4021-1
- 20. Kalkan G, Emre S, Alisik M, Aktas A, Baran P. Dynamic thiol/
disulfide homeostasis in patients with lichen planus. Journal
of Clinical Laboratory Analysis 2019 Jan; 33 (1): e22642.
doi:10.1002/jcla.22642
- 21. Ünal K, Erzin G, Yuksel RN, Alisik M, Erel O. Thiol/disulphide
homeostasis in schizophrenia patients with positive symptoms.
Nordic Journal of Psychiatry 2018; 72 (4): 281-284. doi:
10.1080/08039488.2018.1441906
- 22. Sener S, Akbas A, Kilinc F, Baran P, Erel O et al. Thiol/
disulfide homeostasis as a marker of oxidative stress
in rosacea: a controlled spectrophotometric study.
Cutaneous Ocular Toxicology 2019 Mar; 38 (1): 55-58. doi:
10.1080/15569527.2018.1517124
- 23. Köseoğlu H, Alisik M, Basaran M, Yurekli OT, Solakoglu T et
al. Dynamic thiol/disulphide homeostasis in acute pancreatitis.
Turkish Journal of Gastroenterology 2018; 29 (3): 348-353.
doi: 10.5152/tjg.2018.17499
- 24. Ivanov AI, Korolenko EA, Korolik EV, Firsov SP, Zhbankov
RG et al. Chronic liver and renal diseases differently affect
structure of human serum albumin. Archives of Biochemistry
and Biophysics 2002; 408: 69-77. doi: 10.1016/s0003-
9861(02)00533-7
- 25. Du Y, Su T, Song X, Gao J, Zou D et al. Efficacy and safety of
cinitapride in the treatment of mild to moderate postprandial
distress syndrome–predominant functional dyspepsia. Journal
of Clinical Gastroenterology 2014; 48 (4): 328-335. doi:
10.1097/MCG.0000000000000033
- 26. Yuksel M, Ates I, Kaplan M, Alisik M, Erel O et al. The
dynamic thiol/disulphide homeostasis in inflammatory bowel
disease and its relation with disease activity and pathogenesis.
International Journal of Colorectal Disease 2016; 31: 1229-
1231. doi: 10.1007/s00384-015-2439-8
- 27. Ates¸ I, Ozkayar N, Altay M, Yilmaz FM, Topcuoglu C et al.
Is disulphide/thiol ratio related to blood pressure in masked
hypertension? Clinical and Experimental Hypertension 2016;
38: 150-154. doi: 10.3109/10641963.2015.1060995
- 28. Ates I, Kaplan M, Yuksel M, Mese D, Alisik M et al.
Determination of thiol/disulphide homeostasis in type
1 diabetes mellitus and the factors associated with thiol
oxidation. Endocrine 2016; 51 (1): 47-51. doi: 10.1007/s12020-
015-0784-6
- 29. Kundi H, Ates I, Kiziltunc E, Cetin M, Cicekcioglu H et al. A
novel oxidative stress marker in acute myocardial infarction;
thiol/disulphide homeostasis. American Journal of Emergency
Medicine 2015; 33: 1567-1571. doi: 10.1016/j.ajem.2015.06.016
- 30. Nanda N, Bobby Z, Hamide A. Oxidative stress in anti
thyroperoxidase antibody positive hypothyroid patient. Asian
Journal of Biochemistry 2012; 7: 54-58.
- 31. Ates I, Yilmaz FM, Altay M, Yilmaz N, Berker D et al. The
Relationship between Oxidative Stress and Autoimmunity in
Hashimoto’s Thyroiditis. European Journal of Endocrinology
2015; 173: 791-799. doi: 10.1530/EJE-15-0617
- 32. Baser H, Can U, Baser S, Yerlikaya FH, Aslan U et al. Assesment of
oxidative status and its association with thyroid autoantibodies
in patients with euthyroid autoimmune thyroiditis. Endocrine
2015; 48 (3): 916-923. doi:10.1007/s12020-014-0399-3
- 33. Kurien BT, Scofield H. Autoimmunity and oxidatively modified
autoantigens. Autoimmunity Reviews 2008; 7: 567-573. doi:
10.1016/j.autrev.2008.04.019
- 34. Kaplan M, Ates I, Yuksel M, Ozin YO, Alisik M et al. Thiol/
disulphide homeostasis in celiac disease. World Journal of
Gastrointestinal Pharmacology and Therapeutics 2017 6; 8 (2):
120-126. doi: 10.4292/wjgpt.v8.i2.120
- 35. Thiyagarajan R, Pal P, Pal GK, Subramanian SK, Bobby Z et al.
Cardiovagal modulation, oxidative stress, and cardiovascular
risk factors in prehypertensive subjects: cross-sectional study.
American Journal of Hypertension 2013; 26 (7): 850–857. doi:
10.1093/ajh/hpt025
- 36. Ziegler D, Sohr CG, Nourooz-Zadeh J. Oxidative stress and
antioxidant defense in relation to the severity of diabetic
polyneuropathy and cardiovascular autonomic neuropathy.
Diabetes Care 2004; 27 (9): 2178-2183. doi: 10.2337/
diacare.27.9.2178
- 37. Balta S, Aparci M, Demir M, Ozturk C, Celik T. Ischemiamodified
albumin in patients with seizure. American Journal
of Emergency Medicine 2014; 32 (10): 1282. doi: 10.1016/j.
ajem.2014.06.028
- 38. Piva SJ, Duarte MM, Da Cruz IB, Coelho AC, Moreira AP et
al. Ischemia-modified albumin as an oxidative stress biomarker
in obesity. Clinical Biochemistry 2011; 44 (4): 345-347. doi:
10.1016/j.clinbiochem.2010.12.001
- 39. Caglar GS, Oztas E, Karadag D, Pabuccu R, Demirtas S.
Ischemia-modified albumin and cardiovascular risk markers in
polycystic ovary syndrome with or without insulin resistance.
Fertility and Sterility 2011; 95 (1): 310-313. doi: 10.1016/j.
fertnstert.2010.06.092
- 40. Duarte MM, Rocha JB, Moresco RN, Duarte T, Da Cruz IB et
al. Association between ischemia-modified albumin, lipids and
inflammation biomarkers in patients with hypercholesterolemia.
Clinical Biochemistry 2009; 42 (7-8): 666-671. doi: 10.1016/j.
clinbiochem.2009.01.010
- 41. Kucuk A, Uslu AU, Arslan S, Balta S, Ozturk C et al. Ischemiamodified
albumin and atherosclerosis in patients with familial
mediterranean fever. Angiology 2016; 67 (5): 456-460. doi:
10.1177/0003319715595744
- 42. Capkin E, Karkucak M, Kola M, Karaca A, Capkin AA et al.
Ischemia-modified albumin (IMA): A novel marker of vascular
involvement in Behcet’s disease? Joint Bone Spine 2015; 82 (1):
68-69. doi: 10.1016/j.jbspin.2014.06.007